{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:16:27Z","timestamp":1768288587755,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":5732,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.jpain.2007.10.007","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T17:36:46Z","timestamp":1199295406000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"S","title":["Vaccination to Prevent Herpes Zoster in Older Adults"],"prefix":"10.1016","volume":"9","author":[{"suffix":"Jr.","given":"John W.","family":"Gnann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jpain.2007.10.007_bib1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/infdis\/166.Supplement_1.S35","article-title":"Cell-mediated immunity to varicella-zoster virus","volume":"166","author":"Arvin","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpain.2007.10.007_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/315347","article-title":"Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression","volume":"181","author":"Asanuma","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpain.2007.10.007_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/iai.32.1.24-27.1981","article-title":"Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged","volume":"32","author":"Berger","year":"1981","journal-title":"Infect Immunol"},{"key":"10.1016\/j.jpain.2007.10.007_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/infdis\/166.5.1153","article-title":"Herpes zoster and human immunodeficiency virus infection","volume":"166","author":"Buchbinder","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpain.2007.10.007_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archinte.1982.00340150091017","article-title":"Immune response to varicella-zoster in the aged","volume":"142","author":"Burke","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpain.2007.10.007_bib6","unstructured":"Centers for Disease Control and Prevention: General recommendations on immunization: Recommendations and reports. Morb Mortal Weekly Rep 55(RR-15):1-48, Dec 1, 2006"},{"key":"10.1016\/j.jpain.2007.10.007_bib7","unstructured":"Centers for Disease Control and Prevention: Recommended Adult Immunization Schedule\u2014United States, October 2007\u2013September 2008. Morb Mortal Weekly Rep 56:Q1-Q4, 2007"},{"key":"10.1016\/j.jpain.2007.10.007_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory","volume":"5","author":"Coplan","year":"2004","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2007.10.007_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7326\/0003-4819-89-3-375","article-title":"Herpes zoster-varicella infections in immunocompromised patients","volume":"89","author":"Dolin","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpain.2007.10.007_bib10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","article-title":"The incidence of herpes zoster","volume":"155","author":"Donahue","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpain.2007.10.007_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice: Herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2007.10.007_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF00916011","article-title":"Lymphocyte responses to varicella zoster virus in the elderly","volume":"7","author":"Hayward","year":"1987","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jpain.2007.10.007_bib13","unstructured":"Itzler RF, Pellissier JM, Davies G, Carides G, Cook JR, Schmader K: Zostavax reduces health care encounters for herpes zoster (abstract 860). Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, October 12-15, 2006"},{"key":"10.1016\/j.jpain.2007.10.007_bib14","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1532-5415.2007.01397.x","article-title":"Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older","volume":"55","author":"Kerzner","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2007.10.007_bib15","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1002\/jmv.10364","article-title":"Varicella in Americans from NHANES III: Implications for control through routine immunization","volume":"70","author":"Kilgore","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jpain.2007.10.007_bib16","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella-zoster vaccine for the prevention of herpes zoster","volume":"356","author":"Kimberlin","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2007.10.007_bib17","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1086\/514264","article-title":"Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: Duration of booster effect","volume":"178","author":"Levin","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpain.2007.10.007_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/infdis\/166.2.253","article-title":"Immune response of elderly individuals to a live attenuated varicella vaccine","volume":"166","author":"Levin","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpain.2007.10.007_bib19","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpain.2007.10.007_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003495-200161020-00004","article-title":"Prophylaxis against herpesvirus infections in transplant recipients","volume":"61","author":"Ljungman","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jpain.2007.10.007_bib21","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.vaccine.2006.11.011","article-title":"Safety and immunogenecity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults","volume":"25","author":"Macalalad","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jpain.2007.10.007_bib22","unstructured":"Merck & Co., Inc.: Zoster vaccine live (Oka\/Merck) Zostavax Package Insert. http:\/\/www.fda\/gov\/cber\/label\/zosmer052506LB.htm. Accessed October 1, 2007"},{"key":"10.1016\/j.jpain.2007.10.007_bib23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1212\/WNL.30.6.582","article-title":"Selective decline in cellular immune responses to varicella-zoster in the elderly","volume":"30","author":"Miller","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2007.10.007_bib24","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1212\/WNL.45.12_Suppl_8.S41","article-title":"Immunization to reduce the frequency and severity of herpes zoster and its complications","volume":"45","author":"Oxman","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2007.10.007_bib25","unstructured":"Oxman MN, Levin MJ, Johnson G, Zhang J, Caulfield MJ: The effect of age on clinical and immunologic responses to a herpes zoster vaccine (abstract 858). Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, October 12-15, 2006"},{"key":"10.1016\/j.jpain.2007.10.007_bib26","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2007.10.007_bib27","unstructured":"Oxman MN, Weinberg A, Stanley HA, Johnson GR, Levin MJ, Zhang JH, Caulfield MJ, Hayward AR, Irwin MR, Chan ISF, Clair J, Smith JG, The Shingles Prevention Study Group: VZV-specific immune responses in older adult recipients of a clinically effective herpes zoster vaccine (abstract PP193): Proceedings of the European Union Geriatric Medicine Society, 4th Congress, Geneva, Switzerland, August 23-26, 2006. J Nutr Health Aging 10:39, 2006"},{"key":"10.1016\/j.jpain.2007.10.007_bib28","unstructured":"Oxman MN, Williams HM, Levin MJ, Johnson GR, Zhang JH, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Annunziato PW, Chan ISF, Silber JL, Wang WWB: Efficacy of zoster vaccine according to dermatome region (abstract 2699). Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, December 15-18, 2005"},{"key":"10.1016\/j.jpain.2007.10.007_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Populations-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jpain.2007.10.007_bib30","unstructured":"Schmader K, Saddier P, Johnson G, Wang W, Zhang J, Chan ISF, Levin MJ, Oxman MN: The effect of zoster vaccine on interference of herpes zoster with activities of daily living (abstract 859). Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Canada, October 12-15, 2006"},{"key":"10.1016\/j.jpain.2007.10.007_bib31","unstructured":"Sutradhar SC, Wang WWB, Schlienger K, Stek JE, Xu J, Chan ISF, Silber JL: Comparison of immunogenicity and safety of Zostavax in adults 50 to 59 years old and those > 60 years old (abstract S27). Proceedings of the NFID Tenth Annual Conference on Vaccine Research, Baltimore, MD, April 30-May 2, 2007"},{"key":"10.1016\/j.jpain.2007.10.007_bib32","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0264-410X(99)00510-1","article-title":"Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: A randomized, controlled, dose-response trial","volume":"18","author":"Trannoy","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jpain.2007.10.007_bib33","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.vaccine.2006.10.027","article-title":"Safety and tolerability of a high-potency zoster vaccine in adults >50 or years of age","volume":"25","author":"Tyring","year":"2007","journal-title":"Vaccine"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590007008954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590007008954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:44:47Z","timestamp":1761507887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590007008954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1526590007008954"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2007.10.007","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination to Prevent Herpes Zoster in Older Adults","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2007.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}